Literature DB >> 32955730

Functional retinal outcomes in patients with prediabetes and type 2 diabetes.

Nicole Karson1, Jennyffer Smith1, Morgan Jones1, Ananya Datta1, Kathryn Richdale1, Wendy W Harrison1.   

Abstract

PURPOSE: Type 2 diabetes (T2DM) is a leading cause of visual impairment. Its precursor, prediabetes (preDM), is growing in numbers every year. While it is well known that T2DM causes changes in retinal function early in the disease process, it is likely that some of these changes emerge during the preDM stage. This study evaluates retinal function measures in patients with preDM to determine if there are differences in colour vision, contrast sensitivity (CS), and multifocal electroretinogram (mfERG) measures present before T2DM is diagnosed.
METHODS: The L'Anthony desaturated D-15 test, Mars Chart CS test, and mfERG were administered on the right eye of 43 participants; 15 controls (HbA1c ≤ 5.6%), 17 with preDM (HbA1c 5.7%-6.4%), and 11 with T2DM (either physician diagnosed or with untreated HbA1c ≥ 6.5%). HbA1c values were measured at the time of the other tests. Colour vision confusion scores (CVCS) were calculated from the D-15 using the method developed by Torok. Multivariate regression (which controlled for age differences) was used to evaluate the relationship of HbA1c and functional measures. Kruskal-Wallis tests were also used to evaluate differences between groups with post-hoc analysis.
RESULTS: CVCSs were significantly different between the three groups (p = 0.009). There was an association between higher CVCS and higher HbA1c values across all groups as well as specifically within the preDM group when controlling for age (R2  = 0.29, p = 0.01 and R2  = 0.39, p = 0.02 respectively). Multivariate regression of all of the functional tests together and HbA1c found only colour vision remained significant, indicating that the functional examination metrics may provide redundant data, with similar changes in prediabetes where colour vision may be the strongest indicator early in the process.
CONCLUSIONS: Patients with prediabetes have functional changes that can be measured in the retina before the diagnosis of diabetes, with the L'Anthony D-15 colour vision test providing the strongest association with glucose dysregulation in this population. This has important implications for follow up and screening for diabetes within optometric practices. Further studies are needed to follow these patients over time to see how and when these metrics change.
© 2020 The Authors Ophthalmic & Physiological Optics © 2020 College of Optometrists.

Entities:  

Keywords:  colour vision; contrast sensitivity; mfERG; prediabetes; type 2 diabetes

Year:  2020        PMID: 32955730      PMCID: PMC7606818          DOI: 10.1111/opo.12733

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  22 in total

1.  Contrast sensitivity and its determinants in people with diabetes: SN-DREAMS-II, Report No 6.

Authors:  L Gella; R Raman; S S Pal; S Ganesan; T Sharma
Journal:  Eye (Lond)       Date:  2016-11-18       Impact factor: 3.775

Review 2.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

3.  [Color vision in relation to age: a study of normal values].

Authors:  T Berninger; B Drobner; C Hogg; G Rudolph; G B Arden; A Kampik
Journal:  Klin Monbl Augenheilkd       Date:  1999-07       Impact factor: 0.700

4.  Association of contrast sensitivity with LogMAR visual acuity and glycosylated hemoglobin in non-insulin dependent diabetes mellitus.

Authors:  Shaili Misra; Sandeep Saxena; Poonam Kishore; Shashi K Bhasker; Arvind Misra; Carsten H Meyer
Journal:  J Ocul Biol Dis Infor       Date:  2010-11-03

5.  Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study.

Authors:  Eline E B De Clerck; Jan S A G Schouten; Tos T J M Berendschot; Fleur Goezinne; Pieter C Dagnelie; Nicolaas C Schaper; Miranda T Schram; Coen D A Stehouwer; Carroll A B Webers
Journal:  Acta Ophthalmol       Date:  2017-11-01       Impact factor: 3.761

6.  Color vision and neuroretinal function in diabetes.

Authors:  B E Wolff; M A Bearse; M E Schneck; K Dhamdhere; W W Harrison; S Barez; A J Adams
Journal:  Doc Ophthalmol       Date:  2014-12-17       Impact factor: 2.379

7.  Color vision study to assess the impaired retina-brain cortex pathway in type 2 diabetes: a pilot study in Calabria (Southern Italy).

Authors:  Anna Piro; Antonio Tagarelli; Paolo Lagonia; Giuseppe Nicoletti; Aldo Quattrone
Journal:  Neurol Sci       Date:  2019-05-03       Impact factor: 3.307

Review 8.  Diabetic retinopathy: more than meets the eye.

Authors:  Thomas W Gardner; David A Antonetti; Alistair J Barber; Kathryn F LaNoue; Steven W Levison
Journal:  Surv Ophthalmol       Date:  2002-12       Impact factor: 6.048

9.  Impairment of Colour Vision in Diabetes with No Retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SNDREAMS- II, Report 3).

Authors:  Laxmi Gella; Rajiv Raman; Vaitheeswaran Kulothungan; Swakshyar Saumya Pal; Suganeswari Ganesan; Tarun Sharma
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes.

Authors:  Mariana R P Alves; Raquel Boia; Elisa J Campos; João Martins; Sara Nunes; Maria H Madeira; Ana Raquel Santiago; Frederico C Pereira; Flávio Reis; António F Ambrósio; Filipa I Baptista
Journal:  Mol Vis       Date:  2018-05-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.